Cargando…

Aspirin and antiplatelet treatments in cancer

Platelets have been hypothesized to promote certain neoplastic malignancies; however, antiplatelet drugs are still not part of routine pharmacological cancer prevention and treatment protocols. Paracrine interactions between platelets and cancer cells have been implicated in potentiating the dissemi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tao, Derrick L., Tassi Yunga, Samuel, Williams, Craig D., McCarty, Owen J. T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society of Hematology 2021
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8351882/ https://www.ncbi.nlm.nih.gov/pubmed/33940597 http://dx.doi.org/10.1182/blood.2019003977

Ejemplares similares

The Predictive Value of Inflammation-Related Peripheral Blood Measurements in Cancer Staging and Prognosis
por: Sylman, Joanna L., et al.
Publicado: (2018)

Ibrutinib-Associated Cardiac Tamponade with Concurrent Antiplatelet Therapy
por: Miatech, Jennifer L., et al.
Publicado: (2020)

Tailored antiplatelet therapy can overcome clopidogrel and aspirin resistance - The BOchum CLopidogrel and Aspirin Plan (BOCLA-Plan) to improve antiplatelet therapy
por: Neubauer, Horst, et al.
Publicado: (2011)

Irreversible alteration of extracellular vesicle and cell-free messenger RNA profiles in human plasma associated with blood processing and storage
por: Kim, Hyun Ji, et al.
Publicado: (2022)

Mapping the antiplatelet effects of clopidogrel and aspirin by modified thromboelastography
por: Hemlata,, et al.
Publicado: (2013)

Dissolvable polymeric microneedles loaded with aspirin for antiplatelet aggregation
por: Wang, Baorui, et al.
Publicado: (2023)

Do Aspirin and Other Antiplatelet Drugs Reduce the Mortality in Critically Ill Patients?
por: Lösche, Wolfgang, et al.
Publicado: (2012)

Targeting aspirin resistance with nutraceuticals: a possible strategy for reducing cardiovascular morbidity and mortality
por: DiNicolantonio, James J, et al.
Publicado: (2017)

Ticagrelor as an Alternative Antiplatelet Therapy in Cardiac Patients Non-Sensitive to Aspirin
por: Khan, Hamzah, et al.
Publicado: (2020)

Immature platelets and antiplatelet therapy response to aspirin in Kawasaki disease
por: Pi, Lei, et al.
Publicado: (2018)

Does the timing of aspirin administration influence its antiplatelet effect – review of literature on chronotherapy
por: Miciak-Ławicka, Ewa, et al.
Publicado: (2018)

Aspirin-free antiplatelet regimens after PCI: insights from the GLOBAL LEADERS trial and beyond
por: Wang, Rutao, et al.
Publicado: (2021)

The dogma of aspirin: a critical review of evidence on the best monotherapy after dual antiplatelet therapy
por: Polo Friz, Hernan, et al.
Publicado: (2015)

Risk of recurrent stroke and antiplatelet choice in breakthrough stroke while on aspirin
por: Kim, Joon-Tae, et al.
Publicado: (2020)

Celecoxib Does Not Attenuate the Antiplatelet Effects of Aspirin and Clopidogrel in Healthy Volunteers
por: Lee, Wonjae, et al.
Publicado: (2010)

Effects of colchicine on platelet aggregation in patients on dual antiplatelet therapy with aspirin and clopidogrel
por: Cirillo, Plinio, et al.
Publicado: (2020)

Nutraceutical, Dietary, and Lifestyle Options for Prevention and Treatment of Ventricular Hypertrophy and Heart Failure
por: McCarty, Mark F.
Publicado: (2021)

Determinants of Reduced Antiplatelet Effect of Aspirin in Patients with Stable Coronary Artery Disease
por: Larsen, Sanne Bøjet, et al.
Publicado: (2015)

Ready for takeoff? A critical review of armodafinil and modafinil for the treatment of sleepiness associated with jet lag
por: McCarty, David E
Publicado: (2010)

Dual Antiplatelet Therapy with Clopidogrel and Aspirin Versus Aspirin Monotherapy in Patients Undergoing Coronary Artery Bypass Graft Surgery
por: Qu, Jianyu, et al.
Publicado: (2021)

Lower Antiplatelet Effect of Aspirin in Essential Thrombocythemia than in Coronary Artery Disease
por: Pedersen, Oliver Buchhave, et al.
Publicado: (2021)

Analysis of Gastrointestinal Prophylaxis in Patients Receiving Dual Antiplatelet Therapy with Aspirin and Clopidogrel
por: Morneau, Kathleen M., et al.
Publicado: (2014)

Dapoxetine: an evidence-based review of its effectiveness in treatment of premature ejaculation
por: McCarty, EJ, et al.
Publicado: (2012)

Perioperative management and monitoring of antiplatelet agents: a focused review on aspirin and P2Y(12) inhibitors
por: Mazzeffi, Michael A., et al.
Publicado: (2017)

Safety Comparison of Monotherapy Aspirin to Dual Antiplatelet Therapy Following Coronary Artery Bypass Surgery
por: Nei, Scott D., et al.
Publicado: (2022)

Effect of antiplatelet agents and tyrosine kinase inhibitors on oxLDL-mediated procoagulant platelet activity
por: Zheng, Tony J., et al.
Publicado: (2022)

A Theme Series on Emerging Technologies for Use in the Study, Diagnosis and Treatment of Patients with COVID-19
por: Simmons, Chelsey S., et al.
Publicado: (2020)

Dual Antiplatelet Therapy Using Cilostazol With Aspirin or Clopidogrel: Subanalysis of the CSPS.com Trial
por: Hoshino, Haruhiko, et al.
Publicado: (2021)

Comparative evaluation of antiplatelet effect of lycopene with aspirin and the effect of their combination on platelet aggregation: An in vitro study
por: Sawardekar, Swapna B., et al.
Publicado: (2016)

Antiplatelet effects of aspirin are not affected by the soluble guanylate cyclase activator cinaciguat (BAY 58-2667)
por: Frey, Reiner, et al.
Publicado: (2011)

Antiplatelet Effectivity between Aspirin with Honey on Cardiovascular Disease Based on Bleeding Time Taken on Mice
por: Martina, Sake Juli, et al.
Publicado: (2019)

Antiplatelet Effects of Clopidogrel Vs Aspirin in Virologically Controlled HIV: A Randomized Controlled Trial
por: Marcantoni, Emanuela, et al.
Publicado: (2022)

Aspirin vs Clopidogrel: Antiplatelet Agent of Choice for Those With Recent Bleeding or at Risk for Gastrointestinal Bleed
por: Gosavi, Siddharth, et al.
Publicado: (2023)

Poster 180: Diagnostic Algorithm and Outcomes of Treatment for Neurogenic Pectoralis Minor Syndrome
por: McCarty, Leroy
Publicado: (2022)

Opioid use disorder and treatment: challenges and opportunities
por: Hoffman, Kim A., et al.
Publicado: (2019)

Clinical evidence for the use of aspirin in the treatment of cancer
por: Langley, Ruth E
Publicado: (2013)

The Metabolites of the Dietary Flavonoid Quercetin Possess Potent Antithrombotic Activity, and Interact with Aspirin to Enhance Antiplatelet Effects
por: Stainer, Alexander R., et al.
Publicado: (2019)

NADPH Oxidase Activity in Cerebral Arterioles Is a Key Mediator of Cerebral Small Vessel Disease—Implications for Prevention
por: McCarty, Mark F.
Publicado: (2015)

Asymmetric Dimethylarginine Is a Well Established Mediating Risk Factor for Cardiovascular Morbidity and Mortality—Should Patients with Elevated Levels Be Supplemented with Citrulline?
por: McCarty, Mark F.
Publicado: (2016)

Nutraceutical and Dietary Strategies for Up-Regulating Macroautophagy
por: McCarty, Mark F.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_nnqlmmmur2dd31dcdol9fjpi7t